| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/17/2013 | CN103202867A Application of coreopsis tinctoria flowers in preparation of blood pressure reducing medicament |
| 07/17/2013 | CN103202857A Perivascular Mesenchymal Precursor Cell Induced Blood Vessel Formation |
| 07/17/2013 | CN103202851A Extraction method of hawthorn active components |
| 07/17/2013 | CN103202839A Ginkgolide composition for treating cardiovascular and cerebrovascular diseases |
| 07/17/2013 | CN103202832A Application of acylated tanshinol derivant in prevention and treatment of cardiovascular disease and complication thereof |
| 07/17/2013 | CN103202824A Application of pinitol to pharmacy and health care product |
| 07/17/2013 | CN103202805A Vinpocetine-containing pharmaceutical composition for injection and preparation method thereof |
| 07/17/2013 | CN103202423A Fructus trichosanthis polysaccharide composite capsule and preparation method thereof |
| 07/17/2013 | CN102772375B Creatine phosphate sodium for injection and preparation method for creatine phosphate sodium for injection |
| 07/17/2013 | CN102641358B Pharmaceutical composition for treating pregnancy-induced hypertension (PIH) |
| 07/17/2013 | CN102626510B Traditional Chinese medicine composite for treating diabetic cardiopathy and preparation method and applications thereof |
| 07/17/2013 | CN102579881B Chinese medicinal composition for treating pregnancy-induced hypertension syndrome and preparation method thereof |
| 07/17/2013 | CN102526611B Chinese medicinal composition for treating chronic heart failure |
| 07/17/2013 | CN102526247B Chinese medicine sitting bathing preparation for treating hemorrhoids sore |
| 07/17/2013 | CN102488650B Adenosine cyclophosphate pharmaceutical composition and preparation method thereof |
| 07/17/2013 | CN102485221B Sublingual pharmaceutical composition containing ibutilide and preparation method thereof |
| 07/17/2013 | CN102462787B Chinese medicine composition for treating hypertension and improving hyperlipidemia and preparation method of Chinese medicine composition |
| 07/17/2013 | CN102441129B Traditional Chinese medicine for treating chronic pulmonary heart disease |
| 07/17/2013 | CN102423368B Chinese medicinal composition for treating sequelae of cerebral thrombosis and cerebral hemorrhage, as well as preparation method thereof |
| 07/17/2013 | CN102406678B Preparation method of bear gall dispersible tablet for heart attack |
| 07/17/2013 | CN102379887B Cardiovascular disease treating medicament and preparation method and application thereof |
| 07/17/2013 | CN102274267B Preparation method of vacuum packaged pseudostellaria roots |
| 07/17/2013 | CN102250724B Cordyceps and ginkgo yellow wine as well as preparation method and application thereof |
| 07/17/2013 | CN102206276B Humanized antibodies derived from DD-3B6/22, specific for the D-dimer fragment of fibrin |
| 07/17/2013 | CN102153606B Nucleoside derivatives as well as stereo isomers, pharmaceutically acceptable salts and application thereof |
| 07/17/2013 | CN102146142B Method for preparing astragalus polysaccharides |
| 07/17/2013 | CN102085359B Medical composition containing hirudin and hementerin and application thereof |
| 07/17/2013 | CN102076347B Pharmaceutical composition comprising extracts of huanglian and ku ding cha effective for lowering blood lipid levels |
| 07/17/2013 | CN102058679B Medicine or health-care food composition for treating atherosclerosis |
| 07/17/2013 | CN102020699B Anti-platelet aggregation peptide and application thereof |
| 07/17/2013 | CN102002052B Ginkgolides K and compound thereof as well as preparation method and use thereof |
| 07/17/2013 | CN101883575B Guava extract |
| 07/17/2013 | CN101824455B Soy protein oligopeptide, and preparation method and use thereof |
| 07/17/2013 | CN101641339B Compounds for the prevention and treatment of cardiovascular diseases |
| 07/17/2013 | CN101622242B Bicyclic derivatives as CETP inhibitors |
| 07/17/2013 | CN101573446B Aptamer against midkine and use thereof |
| 07/17/2013 | CN101490036B Factor xa inhibitors |
| 07/17/2013 | CN101374571B Na/K-ATPase ligand |
| 07/17/2013 | CN101312661B Natural high-potency sweetener compositions with improved temporal profile and/or flavor profile, methods for their formulation, and uses |
| 07/16/2013 | US8487003 Treatment of cancer by administration of perfluorooctanoic acid |
| 07/16/2013 | US8487000 4-(3-(2,6-Dimethoxybenzyloxy)phenyl)-4-oxobutyric acid or derivatives for treatment of insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis |
| 07/16/2013 | US8486953 Thienopyrimidines for pharmaceutical compositions |
| 07/16/2013 | US8486885 β-arrestin effectors and compositions and methods of use thereof |
| 07/16/2013 | US8486696 Cell populations which co-express CD49c and CD90 |
| 07/16/2013 | US8486464 Herbal composition for angina pectoris, method to prepare same and uses thereof |
| 07/16/2013 | US8486442 External patch containing estrogen and/or progestogen |
| 07/16/2013 | US8486416 Use of SDF-1 to improve ischemic myocardial function |
| 07/16/2013 | US8486387 Modified two-component gelation systems, methods of use and methods of manufacture |
| 07/16/2013 | CA2697167C Benzimidazole derivatives used as fxr agonists |
| 07/16/2013 | CA2486106C Compounds and methods for inhibiting selectin-mediated function |
| 07/16/2013 | CA2477283C Vascular therapeutic methods and compositions involving the reduction or prevention of c-jun mediated processes |
| 07/16/2013 | CA2448348C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/16/2013 | CA2425665C Coated implantable medical device |
| 07/16/2013 | CA2384948C Therapies for chronic renal failure using one or more integrin antagonists |
| 07/11/2013 | WO2013103902A1 Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form |
| 07/11/2013 | WO2013103896A1 Treating cardiovascular or renal diseases |
| 07/11/2013 | WO2013103842A1 Methods of reducing risk of cardiovascular disease |
| 07/11/2013 | WO2013103688A1 Human soluble receptors for advanced glycation end products (srage), methods of preparing human srage, and treatment methods using srage |
| 07/11/2013 | WO2013103150A1 Acid adduct salt of substituted pyridine compound |
| 07/11/2013 | WO2013103148A1 Collateral blood circulation development promoter |
| 07/11/2013 | WO2013102919A1 Polymorphic forms of ivabradine hydrochloride |
| 07/11/2013 | WO2013102264A1 Compositions and methods for modulating ampa receptor-mediated excitotoxicity |
| 07/11/2013 | WO2013067105A3 Nicotinic receptor non-competitive modulators |
| 07/11/2013 | WO2013065015A3 Butea monosperma and curcuma longa extracts for the prevention and treatment diabetic retinopathy and cataract |
| 07/11/2013 | WO2013052787A3 Membrane activated chelators and use in the prevention and treatment of parasitic infection |
| 07/10/2013 | EP2612922A1 Eggshell membrane solubilization method using enzymes |
| 07/10/2013 | EP2612703A2 Particulate materials |
| 07/10/2013 | EP2612671A1 A clinical preparation of scutellarin and the preparation method thereof |
| 07/10/2013 | EP2612659A1 Panaxatriol saponins enteric pellet, capsule comprising same and method for preparing same |
| 07/10/2013 | EP2611831A1 Treatment of myocardial infarction using tgf - beta antagonists |
| 07/10/2013 | EP2611802A1 Bicyclic aza heterocycles, and use thereof |
| 07/10/2013 | EP2611462A2 Peptide or peptide complex binding to 2 integrin and methods and uses involving the same |
| 07/10/2013 | CN203043010U Nifedipine sustained-release tablet (II) |
| 07/10/2013 | CN1990473B Tri-substituted 1H-imidazoles compounds, preparation method and pharmaceutical composition and pharmacy use thereof |
| 07/10/2013 | CN103201292A Treatment of myocardial infarction using TGF-[beta] antagonists |
| 07/10/2013 | CN103201285A Modified relaxin polypeptides and their uses |
| 07/10/2013 | CN103201274A Pyrrolidine derivatives used as cathepsin inhibitors |
| 07/10/2013 | CN103201267A Ampk-activating heterocyclic compounds and methods for using the same |
| 07/10/2013 | CN103201257A Substituted amino bisphenyl pentanoic acid derivatives as nep inhibitors |
| 07/10/2013 | CN103200952A Treatment of diseases |
| 07/10/2013 | CN103194515A Method for preparing silkworm pupa protein ACE (angiotensin-I converting enzyme) inhibitory peptide by continuous enzyme membrane reaction, and product and application thereof |
| 07/10/2013 | CN103194489A Novel cationic liposome nucleic acid pharmaceutical preparation as well as preparation method and application thereof |
| 07/10/2013 | CN103194361A Pseudo-ginseng wine and preparation method thereof |
| 07/10/2013 | CN103193864A Delta crystalline form of the arginine salt of perindopril, a process for its preparation, and pharmaceutical compositions containing it |
| 07/10/2013 | CN103193792A New compound for treating ischemic cardiovascular and cerebrovascular diseases |
| 07/10/2013 | CN103193789A Optically active butylphthalide open-ring derivative, preparation method and medical application |
| 07/10/2013 | CN103193780A Use of 4,7-dihydrotetrazyl[1,5-alpha]pyrimidine compound and its derivatives in preparation of drug for prevention or treatment on cerebral hemorrhage |
| 07/10/2013 | CN103193773A Pyridyloxyindoles inhibitors of VEGF-R2 and use thereof for treatment of diseases |
| 07/10/2013 | CN103193772A Preparation method and application of substituted aryl propionic berberine ion-pair compound |
| 07/10/2013 | CN103193770A Substituted benzothiazole compound as well as preparation method and application thereof |
| 07/10/2013 | CN103193742A Xanthatin derivative and medicine use thereof |
| 07/10/2013 | CN103193700A Benzenesulfonic acid levamlodipine crystal and pharmaceutical composition containing same |
| 07/10/2013 | CN103193661A Potassium aspartate crystal, and preparation method of potassium magnesium aspartate drug composition |
| 07/10/2013 | CN103193642A Carvacrol derivatives and synthetic method and application thereof |
| 07/10/2013 | CN103193627A Crystal form, preparation method and application of prostaglandin analogue |
| 07/10/2013 | CN103193626A Crystal form, preparation method and application of prostaglandin analogue |
| 07/10/2013 | CN103191431A Coenzyme Q10 sodium chloride injection uneasy to crystallize and preparation method thereof |
| 07/10/2013 | CN103191415A Application of fibroblast growth factor-21 mature peptide in preparing medicine for treating hypertension |
| 07/10/2013 | CN103191402A Medicament for treating rheumatic heart disease and preparation method thereof |
| 07/10/2013 | CN103191367A Collateral dredging and blood pressure reducing capsules |